Research Information System
Pamukkale Medical Journal, vol.13, no.1, pp.19-26, 2020 (Scopus)
Purpose: Laparoscopic sleeve gastrectomy (LSG) has become a widely used primary bariatric surgical technique in recent years. We aimed to investigate the short and midterm effects of LSG on weight loss and its effects on comorbid hypertension (HT) and type 2 diabetes mellitus (T2DM). Materials and methods: 82 patients who underwent LSG between January 2009 and December 2011 and whose postoperative 6-month, 1-year, and 3-year follow-up records were available were included in this retrospective study. Preoperative height/weight values, comorbidities, drug use for HT and/or T2DM, and changes in postoperative 6-month, 1-year, 3-year, and 5-year data were collected. Results: Comparing to the preoperative data, decrease in body mass index (BMI) at the postoperative 6-month, 1-year, and 3-year follow-ups was statistically significant (p=0.0001, for each). A higher increase in BMI was observed at the 3-year follow-up than at the 1-year follow-up (p=0.0001). A decrease in the requirement of oral antidiabetics (OAD) and antihypertensives was observed at the postoperative 3-year compared to the preoperative data (p=0.0001, for each). Conclusion: LSG, which can be applied as a primary treatment in the surgical treatment of morbid obesity, is a very effective and reliable method with low mortality and morbidity rates. In addition, it facilitates significant regression in comorbidities such as HT and T2DM. Although there is some weight gain in the midterm; short and midterm results of LSG indicates that it is an effective surgical technique.